BlackRock, Inc. 13D and 13G filings for Aura Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-17 6:05 pm Purchase | 2025-09-30 | 13G | Aura Biosciences, Inc. AURA | BlackRock Inc. BLK | 3,336,027 5.400% | 298,104 (+9.81%) | Filing |
| 2025-07-16 7:02 pm Sale | 2025-06-30 | 13G | Aura Biosciences, Inc. AURA | BlackRock Inc. BLK | 3,037,923 4.900% | -122,491 (-3.88%) | Filing |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Aura Biosciences, Inc. AURA | BlackRock Inc. BLK | 3,160,414 6.400% | 0 (Unchanged) | Filing |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Aura Biosciences, Inc. AURA | BlackRock Inc. BLK | 3,160,414 6.400% | 3,160,414 (New Position) | Filing |